Skip to main content

Table 2 Reimbursement drug list in Hangzhou and Baoji in 2010

From: Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji

  Class Aa Class Bb
Western medicine Chinese patent medicine Reimbursement by insurance Western medicine Chinese patent medicine Reimbursement by insurance
National-level 349 154 100% 791 833
Hangzhou 349 154 100% 866 951 80%, 97% and 99% based on drug types
Baoji 349 154 100% 983 961 85%
  1. a Class A drugs are those necessary for clinical use, with good effectiveness and low price. The list of Class A drugs is made by the central government and is identical nationwide
  2. b Class B drugs are those optional for clinical use, with similar effectiveness but higher price compared with Class A drugs. The list of Class B drugs is made by the municipal government